DK1054885T3 - Benzisoxasolderivater med D4-antagonistisk virkning - Google Patents

Benzisoxasolderivater med D4-antagonistisk virkning

Info

Publication number
DK1054885T3
DK1054885T3 DK99914450T DK99914450T DK1054885T3 DK 1054885 T3 DK1054885 T3 DK 1054885T3 DK 99914450 T DK99914450 T DK 99914450T DK 99914450 T DK99914450 T DK 99914450T DK 1054885 T3 DK1054885 T3 DK 1054885T3
Authority
DK
Denmark
Prior art keywords
amino
sulfonyl
group
dialkyl
alkoxy
Prior art date
Application number
DK99914450T
Other languages
English (en)
Inventor
Hartog Jacobus A J Den
Steen Bartholomeus J Van
Martinus T M Tulp
Eric Ronken
Cornelis G Kruse
Josephus H M Lange
Gerben M Visser
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of DK1054885T3 publication Critical patent/DK1054885T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK99914450T 1998-02-09 1999-02-05 Benzisoxasolderivater med D4-antagonistisk virkning DK1054885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98200400 1998-02-09
PCT/EP1999/000852 WO1999040067A2 (en) 1998-02-09 1999-02-05 Benzisoxazole derivatives having d4-antagonistic activity

Publications (1)

Publication Number Publication Date
DK1054885T3 true DK1054885T3 (da) 2007-10-15

Family

ID=8233376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99914450T DK1054885T3 (da) 1998-02-09 1999-02-05 Benzisoxasolderivater med D4-antagonistisk virkning

Country Status (11)

Country Link
US (1) US6335326B1 (da)
EP (1) EP1054885B1 (da)
JP (1) JP4627882B2 (da)
AT (1) ATE367389T1 (da)
AU (1) AU3327399A (da)
CA (1) CA2320120C (da)
DE (1) DE69936572T2 (da)
DK (1) DK1054885T3 (da)
ES (1) ES2291023T3 (da)
PT (1) PT1054885E (da)
WO (1) WO1999040067A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4627882B2 (ja) 1998-02-09 2011-02-09 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ D4−アンタゴニスト活性を有するベンズイソキサゾール誘導体
PT1216249E (pt) * 1999-09-14 2004-04-30 Aventis Pharma Inc Derivados de etilicos e propilicos insubstituidos de tienoisoxazol-fenoxi uteis como antagonistas d4
DK1216250T3 (da) * 1999-09-14 2004-02-23 Aventis Pharma Inc Thienoisoxazolyl- og thienylpyrazolyl-phenoxy- substituerede propylderivater som D4-antagonister
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
ATE247110T1 (de) * 1999-09-14 2003-08-15 Aventis Pharma Inc Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
AU2002258506A1 (en) 2001-03-12 2002-09-24 The Mclean Hospital Corporation Dopamine d4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
US8816090B2 (en) * 2005-02-25 2014-08-26 Pfizer Inc. Benzisoxazole derivatives
WO2009013212A2 (en) * 2007-07-26 2009-01-29 F. Hoffmann-La Roche Ag Dual modulators of 5-ht2a and d3 receptors
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
CA2116117A1 (en) 1991-08-22 1993-03-04 Hiroyuki Sueoka Benzisoxazole compound and use thereof
JPH0641125A (ja) * 1992-03-26 1994-02-15 Yoshitomi Pharmaceut Ind Ltd ベンゾイソオキサゾール化合物およびその用途
DK60593D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
FR2749304B1 (fr) * 1996-06-04 1998-06-26 Adir Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP4627882B2 (ja) * 1998-02-09 2011-02-09 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ D4−アンタゴニスト活性を有するベンズイソキサゾール誘導体

Also Published As

Publication number Publication date
EP1054885B1 (en) 2007-07-18
US6335326B1 (en) 2002-01-01
EP1054885A2 (en) 2000-11-29
AU3327399A (en) 1999-08-23
CA2320120A1 (en) 1999-08-12
DE69936572T2 (de) 2008-06-19
ES2291023T3 (es) 2008-02-16
WO1999040067A3 (en) 1999-11-25
CA2320120C (en) 2009-08-11
DE69936572D1 (de) 2007-08-30
ATE367389T1 (de) 2007-08-15
JP4627882B2 (ja) 2011-02-09
PT1054885E (pt) 2007-10-03
JP2002502842A (ja) 2002-01-29
WO1999040067A2 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
DK0858461T3 (da) Kondenserede tropanderivater som neurotransmittergenoptagelsesinhibitorer
DK1054885T3 (da) Benzisoxasolderivater med D4-antagonistisk virkning
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
MEP61208A (en) Novel compounds having inhibitory activity against sodium-dependant transporter
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
MY114679A (en) Aroyl-piperidine derivatives
NO20033385L (no) Fuserte heterocykliske forbindelser
TR199902724T2 (xx) Dopamine D3 resept�rleri mod�lat�rleri olarak tetrahidroisokuinolin t�revleri.
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
ZA939068B (en) Amine derivatives
EA199901062A1 (ru) Производные хинолин-4-карбоксамида как антагонисты рецепторов нк-2 и нк-3
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
NO305287B1 (no) AMPA antagonister
PE20060770A1 (es) Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1
HUP9700955A2 (hu) Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
PE20001384A1 (es) Derivados de acetamida no peptidicos como antagonistas de receptor de nk1
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DE69907636D1 (de) 2-aminochinolinderivate mit d4-agonistischer wirkung
DK0712406T3 (da) Kondenserende indolderivater som 5-HT4-receptorantagonister
NO954769L (no) 3-(indol-3-yl)propensyrederivater som NMDA-antagonister
ES2132748T3 (es) Herbicidas de carbamato.
AR014847A1 (es) 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
ES2161892T3 (es) Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1.